Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2521 AL 2535

Innovative therapeutic strategies using ADHD medications tailored to the behavioral characteristics of patients with chronic pain

Kasahara S, Takahashi M, Suto T, Morita T, Obata H, Niwa SI.

Front Pharmacol. 2025 Feb 26;16:1500313. doi: 10.3389/fphar.2025.1500313. eCollection 2025.

Effects of different exercises on improving gait performance in patients with Parkinson's disease: a systematic review and network meta-analysis

Li Y, Huang J, Wang J, Cheng Y.

Front Aging Neurosci. 2025 Feb 26;17:1496112. doi: 10.3389/fnagi.2025.1496112. eCollection 2025.

[Overview of therapeutic strategies for motor disturbances in Parkinson's disease]

Delgoffe H, Garraux G.

Rev Med Liege. 2025 Mar;80(3):142-150.

Total meibomian gland loss in Parkinson's disease

Dandekar P, Singh S.

Orbit. 2025 Oct;44(5):625-627. doi: 10.1080/01676830.2025.2475840. Epub 2025 Mar 13.

[REM-Sleep-Behavior Disorder - More Than a Simple Parasomnia]

Schäfer C, Brill AK, Wulf MA, Schmidt M, Bassetti CL.

Praxis (Bern 1994). 2025 Feb;114(2):51-55. doi: 10.23785//PRAXIS.2025.02.004.

The Gut-Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications

Menozzi E, Schapira AHV, Borghammer P.

Mov Disord Clin Pract. 2025 Jul;12(7):904-916. doi: 10.1002/mdc3.70029. Epub 2025 Mar 13.

A narrative review of the placebo effect: historical roots, current applications, and emerging insights

Ozpolat C, Okcay Y, Ulusoy KG, Yildiz O.

Eur J Clin Pharmacol. 2025 May;81(5):625-645. doi: 10.1007/s00228-025-03818-6. Epub 2025 Mar 13.

Comparing In vitro Protein Aggregation Modelling Using Strategies Relevant to Neuropathologies

Nadais A, Martins I, Henriques AG, Trigo D, da Cruz E Silva OAB.

Cell Mol Neurobiol. 2025 Mar 13;45(1):24. doi: 10.1007/s10571-025-01539-z.

A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson's disease: results of a mixed methods feasibility study

Nijhuis FAP, Schippers B, Bloem BR, Post B, Meinders MJ.

J Neurol. 2025 Mar 13;272(4):269. doi: 10.1007/s00415-025-12972-x.

The Potential of cfDNA as Biomarker: Opportunities and Challenges for Neurodegenerative Diseases

Aydın Ş, Özdemir S, Adıgüzel A.

J Mol Neurosci. 2025 Mar 13;75(1):34. doi: 10.1007/s12031-025-02317-8.

Deep brain stimulation in Parkinson's disease: a comparison of accuracy and clinical outcomes of frame-based, frameless and frameless fiducial-less techniques

Ricciuti RA, Ottaviani MM, Mancini F, Marano M, Marruzzo D, Barbieri F, Paracino R, De Domenico P, Pagano S, Di Lazzaro V, Dobran M.

Neurol Sci. 2025 Jun;46(6):2675-2685. doi: 10.1007/s10072-025-08102-0. Epub 2025 Mar 13.

Non-nystagmus hyperkinetic eye movement disorders

Certo F, Salvucci G, Casellato C, Gambini C, Oggioni GD, Bocci T, Priori A.

Neurol Sci. 2025 Jul;46(7):3021-3038. doi: 10.1007/s10072-024-07873-2. Epub 2025 Mar 13.

Integrated genetic analysis and single cell-RNA sequencing for brain image-derived phenotypes and Parkinson's disease

Pan L, Yang L, Ding W, Hu Y, Yang W, Wang J, Zhang Z, Fan K, Sun Z, Liang Y, Lin X, Chen J, Zhang Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2025 Apr 2;138:111317. doi: 10.1016/j.pnpbp.2025.111317. Epub 2025 Mar 11.

Reconsidering brain MRI in apparently classical Parkinson's disease: one-time structural imaging for every patient?

Maas RPPWM, Koek HL, Meijer FJA, Bloem BR.

Pract Neurol. 2025 Nov 13;25(6):516-519. doi: 10.1136/pn-2025-004529.

Essential tremor: tips and tricks

Lapeña-Motilva J, Sánchez-Ferro Á, Méndez-Guerrero A, Rábano-Suárez P, Benito-León J.

Pract Neurol. 2025 Jul 14;25(4):313-322. doi: 10.1136/pn-2024-004094.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias